- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07928687
Feasibility Study of an Outdoor Strength Training Program for Older Adults
Development and Implementation of Resistance Training Programs in Community-dwelling Older Adults Using Outdoor Activity Benches: a Feasibility and Pilot Study.
In order to promote healthy ageing and independent living, the World Health Organization recommends older adults to engage in resistance exercise at least twice weekly. However, only a minority of the older population complies with these guidelines, stressing the urgent need to develop comprehensive strategies to implement resistance exercise programs in the community. This PhD project will be performed in close collaboration with IPitup vzw, who developed outdoor activity benches, an accommodating smartphone app with exercise instructions and training courses as a low-cost modality for resistance exercise in the general population. The aim is to build upon these existing structures and develop an optimized, progressive resistance exercise program for community-dwelling older adults, which can be performed in small groups without the need for specialized training experts. The program's feasibility, defined in terms of safety, adherence, usability and acceptability, will be tested.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Prof. Christophe Delecluse
- Número de teléfono: +32 16 32 90 76
- Correo electrónico: christophe.delecluse@kuleuven.be
Copia de seguridad de contactos de estudio
- Nombre: Lien Valepyn
- Número de teléfono: +32 488 84 85 97
- Correo electrónico: lien.valepyn@kuleuven.be
Ubicaciones de estudio
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Bélgica, 3000
- Reclutamiento
- KU Leuven - Department of Movement Sciences
-
Contacto:
- Prof. Christophe Delecluse
- Número de teléfono: +32 16 32 90 76
- Correo electrónico: christophe.delecluse@kuleuven.be
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Community-dwelling adults
- At least 65 years old
Exclusion Criteria:
- Participation in an interventional study with an investigational medicinal product (IMP) or device
- Systematic engagement in resistance exercise during the past year
- Self-reported, unstable cardiovascular disease, neuromuscular disease, acute infection or fever
- Self-reported, surgery in the past year
- Self-reported injuries that result in the inability to perform study-related tasks
- Inability to understand the test and training procedures because of cognitive problems
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Peer-supported outdoor strength training
Participants take part in a 6-week outdoor strength training program using activity benches and a smartphone application. Training is performed in small groups of six community-dwelling older adults. Within each group, one participant acts as a peer coach and provides practical support and motivation. |
2x/week, 35-45min sessions at the outdoor activity bench |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of Participants Experiencing Adverse Events
Periodo de tiempo: Throughout the 6-week intervention
|
Safety of the intervention, assessed as the number of participants experiencing one or more adverse events related to testing or training sessions during the intervention period. |
Throughout the 6-week intervention
|
|
Participant Adherence Rate
Periodo de tiempo: Throughout the 10-week study period
|
Adherence to the intervention, assessed as the proportion of participants who complete the intervention and post-intervention assessments. And assessed as the percentage of scheduled training sessions attended by participants during the 6-week intervention. |
Throughout the 10-week study period
|
|
System Usability Scale (SUS)
Periodo de tiempo: Post-intervention at week 9
|
Usability of the intervention will be assessed using the System Usability Scale (SUS), a 10-item questionnaire yielding a total score ranging from 0 to 5. Five items are positively worded, for which higher response scores indicate greater usability, while five items are negatively worded and are reverse-scored, such that lower response scores indicate greater usability. |
Post-intervention at week 9
|
|
Net Promoter Score (NPS)
Periodo de tiempo: Post-intervention at week 9
|
Acceptability of the intervention, assessed using the Net Promoter Score (NPS), based on participants' likelihood of recommending the programme to others. Scores range from 0 to 10, with higher scores indicating greater acceptability and willingness to recommend the intervention. |
Post-intervention at week 9
|
|
Participant Acceptability of the Intervention
Periodo de tiempo: Post-intervention at week 9
|
Acceptability of the intervention, assessed through participant feedback regarding the peer-led delivery model and the appropriateness of training intensity and progression. Responses will be summarized descriptively. |
Post-intervention at week 9
|
|
Completion Rate of Data Collection Procedures
Periodo de tiempo: Over the 10-week study period
|
Feasibility of data collection procedures, assessed as the proportion of planned laboratory-based assessments, questionnaire assessments, and IPitup app-based assessments successfully completed by participants. Higher percentages indicate greater feasibility of the data collection procedures. |
Over the 10-week study period
|
|
Change in Lower Limb Muscle Strength and Power
Periodo de tiempo: Baseline at week 1 and post-intervention at week 9
|
Preliminary effects of the intervention on muscle strength and power, assessed as the change in lower limb muscle strength and power from baseline to post-intervention. Muscle strength and power will be measured using the predefined study strength assessment protocol. Higher values indicate greater muscle strength and power. |
Baseline at week 1 and post-intervention at week 9
|
|
Implementation Barriers and Facilitators Identified During Focus Groups
Periodo de tiempo: Post-intervention at week 10
|
Implementation barriers and facilitators will be explored through semi-structured focus groups conducted following the intervention. Audio recordings will be transcribed verbatim and analysed using qualitative thematic analysis. Identified barriers and facilitators will be categorized into themes to inform optimization of a future randomized controlled trial. |
Post-intervention at week 10
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- S71971
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .